Hahaha

Salud Mental 2011;34:415-420

TOC pediátrico, revisión del tratamiento

Trastorno obsesivo-compulsivo en niños y adolescentes: una revisión del tratamiento
Rosa Elena Ulloa Flores,1 LinoPalacios Cruz,2 Tizbé del Rosario Sauer Vera3
Artículo original

SUMMARY
Obsessive-compulsive disorder (OCD) in children and adolescents is a chronic disease with poor prognosis. This articleincludes recommendations for the assessment and multidisciplinary treatment of pediatric patients with OCD, which includes education, pharmacological and psychotherapeutic interventions. Theevaluation must include rating scales for the severity and functional impairment, such as the Yale Brown Scale and the Child Obsessive-Compulsive Impact Scale. Drug treatment is based on serotoninreuptake inhibitors (SRIs). The Food and Drug Administration approved clomipramine (CMI), sertraline, fluvoxamine and fluoxetine in this age group. Although CMI has a superior effect size than the SRIs,side effects have limited its use as a first choice. Rulizole, a glutamate antagonist, has shown tolerability and efficacy as adjunctive therapy. Comorbidity, particularly with externalizingdisorders, can moderate the treatment response, thus the addition of other drugs should be considered. Psychoeducation is aimed at improving the knowledge about the illness and improving the patient´sfunctioning. Cognitive-behavioral psychotherapy (CBT) has been recommended as a first treatment choice. However, the limited availability of specialists who can conduct it in the highly demandedpsychiatric services in Mexico lead to recommend it as an additional treatment for patients who are already receiving psychotropic drugs and need other interns Current treatment of pediatric OCDincludes SRIs and psychosocial interventions and the management of comorbid disorders. Key words: Obsessive-compulsive disorder, pediatric, treatment, antidepressants, cognitive behavioral the